₹17.8
-0.1 (-0.3%)![]()
We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.
Unlock Stock of the Month
T&C*
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 17.82 | Bearish |
| 10-DMA | 17.93 | Bearish |
| 20-DMA | 18.11 | Bearish |
| 50-DMA | 18.81 | Bearish |
| 100-DMA | 17.08 | Bullish |
| 200-DMA | 17.43 | Bullish |
%
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Operating Expenses | 10,323 | 10,432 | 12,719 | 16,630 | 14,596 |
| Other Income | 2,282 | 2,454 | 3,885 | 1,355 | 2,351 |
| Operating Profit | 15,952 | 21,000 | 26,247 | 12,560 | 13,478 |
| Interest | 3,749 | 4,142 | 4,492 | 5,597 | 5,561 |
| Depreciation | 4,728 | 4,702 | 4,651 | 4,642 | 4,813 |
| Profit Before Tax | 7,474 | 12,156 | 12,492 | 2,254 | 3,105 |
| Consolidated Net Profit | 4,506 | 8,136 | 10,220 | 554 | 1,075 |
| Adjusted EPS | 1 | 1 | 1 | --- | --- |
Below figures are in Rs. Crores
| Particulars | Sep-2024 | Dec-2024 | Mar-2025 | Jul-2025 | Sep-2025 |
|---|---|---|---|---|---|
| Sales | 1,70,754 | 1,35,936 | 1,28,552 | 1,22,189 | 1,05,161 |
| Expenses | 63,042 | 56,557 | 52,457 | 45,459 | 34,856 |
| Operating Profit | 1,07,712 | 79,379 | 76,096 | 76,730 | 70,304 |
| OPM % | 63% | 58% | 59% | 63% | 67% |
| Other Income | 33,912 | 31,759 | 27,333 | 24,879 | 18,947 |
| Interest | 77,780 | 58,584 | 59,248 | 62,137 | 53,713 |
| Depreciation | 2,345 | 1,681 | 1,385 | 1,277 | 1,221 |
| Profit Before Tax | 61,498 | 50,873 | 42,796 | 38,195 | 34,318 |
| Tax % | 25% | 25% | 26% | 29% | 35% |
| Net Profit | 46,149 | 38,151 | 31,857 | 27,296 | 22,446 |
| EPS in Rs | 83 | 69 | 58 | 50 | 42 |
Below figures are in Rs. Crores
| Particulars | Mar-2026 | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|---|
| Share Capital | 1,06,590 | 1,06,590 | 1,06,590 | 1,06,590 | 1,06,590 |
| Total Reserves | 20,733 | 16,222 | 8,086 | -2,135 | -2,696 |
| Long-Term Borrowings | --- | --- | --- | --- | --- |
| Total Non-Current Liabilities | 36,708 | 39,220 | 40,480 | 42,556 | 46,654 |
| Other Current Liabilities | 9,224 | 9,418 | 10,051 | 17,347 | 13,890 |
| Short Term Borrowings | 3,507 | 4,160 | 4,119 | 4,156 | 4,387 |
| Total Liabilities | 1,80,828 | 1,77,856 | 1,73,033 | 1,72,850 | 1,72,261 |
| Capital Work in Progress | 1,842 | 1,829 | 1,943 | 3,803 | 3,950 |
| Long Term Loans & Advances | 2,071 | 3,418 | 2,390 | 1,879 | 2,465 |
| Currents Investments | --- | --- | --- | --- | --- |
| Short Term Loans and Advances | 6,756 | 6,238 | 5,392 | 9,696 | 6,282 |
| Total Current Assets | 43,176 | 38,174 | 32,544 | 30,682 | 25,042 |
| Total Assets | 1,80,828 | 1,77,856 | 1,73,033 | 1,72,850 | 1,72,261 |
| Adjusted Book Value | 13 | 12 | 11 | 10 | 10 |
Investment Calculator
| Symbol | Change% |
|---|---|
| SUMICHEM | 502.3(14%) |
| ZENSARTECH | 516.1(10%) |
| AEGISVOPAK | 257.43(10%) |
| ECLERX | 1488.8(7%) |
| KAYNES | 3333.8(6%) |
Get Your Portfolio Reviewed

Stay Updated with Our Market Newsletters